NCT06230536 MARIMPACH : Contribution of High-resolution Manometry With Impedancemetry for the Evaluation of Esophageal Clearance in Achalasia
| NCT ID | NCT06230536 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Esophageal Achalasia |
| Study Type | OBSERVATIONAL |
| Enrollment | 104 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 104 participants in total. It began in 2024-02-01 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Outcome after treatment of achalasia is usually assessed by the Eckardt score (ES). The timed barium esophagogram (TBE) is used to objectively assess esophageal clearance after treatment. High-resolution manometry with impedancemetry (HRiM) provides information on esophageal clearance of liquids in addition to motility parameters. The aim of this study was to compare esophageal clearance determined by HRiM and TBE in patients with achalasia treated by POEM.
Eligibility Criteria
Inclusion Criteria: * The patients included are all patients treated by POEM at Bordeaux University Hospital between October 2020 and September 2024. Exclusion Criteria: * Primary POEM failure, lost to follow-up, absence of completion of the ES, TBE or HRiM pre or post poem at 3 months.
Contact & Investigator
Arthur BERGER, MD
PRINCIPAL INVESTIGATOR
University Hospital, Bordeaux
Frequently Asked Questions
Who can join the NCT06230536 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Esophageal Achalasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06230536 currently recruiting?
Yes, NCT06230536 is actively recruiting participants. Contact the research team at arthur.berger@chu-bordeaux.fr for enrollment information.
Where is the NCT06230536 trial being conducted?
This trial is being conducted at Pessac, France.
Who is sponsoring the NCT06230536 clinical trial?
NCT06230536 is sponsored by University Hospital, Bordeaux. The principal investigator is Arthur BERGER, MD at University Hospital, Bordeaux. The trial plans to enroll 104 participants.